SenesTech (SNES) announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase an aggregate of 1,458,872 shares of the company’s common stock originally issued by the company on March 11, at the existing exercise price of $2.90 per share. The closing of the warrant exercise transaction is expected to occur on or about July 1, subject to satisfaction of customary closing conditions. H.C. Wainwright is acting as the exclusive placement agent for the transaction.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNES:
- SenesTech Registers Additional Shares for Capital Raising
- SenesTech’s Evolve rodent birth control tested in Hong Kong, San Francisco
- SenesTech announces end of field trial of Evolve Rat Birth Control
- SenesTech files to sell 1.52M shares of common stock for holders
- SenesTech says Baltimore transitioning to a broader deployment of Evolve